SPINK1 and glioma: SPINK1 was a poor prognostic marker in cohorts of glioma, head and neck cancer, liver cancer, pancreatic cancer, renal cancer, and gastric cancer, while patients with colorectal cancer, urothelial cancer, and ovarian cancer expressing high SPINK1 levels are associated with favorable outcomes.